-+ 0.00%
-+ 0.00%
-+ 0.00%

VERTEX PHARMACEUTICALS INCORPORATED : UBS RAISES TARGET PRICE TO $615 FROM $585

Reuters·09/28/2026 13:21:31

Please log in to view news